Zebrafish Models for Human Skeletal Disorders

Manuel Marí-Beffa1,2, Ana B Mesa-Román1, Ivan Duran1,2

  • 1Department of Cell Biology, Genetics and Physiology, Faculty of Sciences, University of Málaga, IBIMA, Málaga, Spain.

Frontiers in Genetics
|September 7, 2021
PubMed

Insights

Zebrafish models offer a versatile platform for studying human skeletal dysplasias, aiding in the development of new chemical treatments. This review aligns zebrafish research with the International Skeletal Dysplasia Society

Area of Science:

  • Genetics
  • Developmental Biology
  • Pharmacology

Background:

  • The International Skeletal Dysplasia Society updated its classification of genetic skeletal disorders in 2019.
  • Understanding the genetic basis of these disorders is crucial for diagnosis and research.
  • Zebrafish offer a valuable model system for studying human skeletal diseases.

Purpose of the Study:

  • To review the current state of zebrafish models for genetic skeletal disorders.
  • To align zebrafish research with the 2019 Nosology and Classification of Genetic Skeletal Disorders.
  • To encourage research that bridges the gap between zebrafish studies and clinical applications.

Main Methods:

  • Review of existing literature on zebrafish models for skeletal dysplasias.
  • Categorization of zebrafish models based on the 2019 Nosology Committee's classification.
  • Analysis of the 'aquarium to bedside' approach in this field.

Main Results:

  • Over 80 zebrafish models for skeletal disorders are currently available.
  • Zebrafish models provide a cost-effective and versatile platform for research.
  • The review systematically presents these models according to the established nosology.

Conclusions:

  • Zebrafish research is a promising avenue for developing treatments for human skeletal dysplasias.
  • Aligning research with clinical nosology is essential for translational success.
  • Further research is needed to fully leverage zebrafish models for clinical benefit.

Related Concept Videos